Characteristics | Valuea |
---|---|
Centres | |
Centre 1 | 38 (29.2%) |
Centre 2 | 33 (25.5%) |
Centre 3 | 31 (23.8%) |
Centre 4 | 28 (21.5%) |
Cause of cirrhosis | |
Metabolic | 28 (21.5%) |
Cholestatic including BA | 92 (70.7%) |
Auto-immune | 4 (3%) |
Drug | 4 (3%) |
Infectious | 2 (1.5%) |
Female | 58 (44.6%) |
Age (months) | 41 [1.0; 200] |
Weight (kg) | 8.7 [6.0; 18.5] |
Reason for admission | |
ACLF | 23 (17.7%) |
GI bleeding | 42 (32.3%) |
Neurological | 4 (3%) |
Respiratory | 18 (13.8%) |
Sepsis | 24 (18.4%) |
Other | 19 (14.6%) |
Bilirubin (µmol/L) | 216 [89; 403] |
INR | 1.89 [1.2; 3.42] |
pCLIF-SOFA score | 8.6 [0; 21] |
PELD score | 18.6 [– 14.7; 47.9] |
KDIGO stage (1 + 2, 3) | 17 (13%), 23 (17.7%) |
PIM2 score | 13.4% [12;4; 14.4] |
Mechanical ventilation | 35 (27%) |
Sepsis and septic shock (admission + hospitalization) | 30 + 34 (49.2%) |
Sepsis | 38 (59.4%) |
Septic shock | 26 (40.6%) |
PICU-LOS (days) | 13 [2; 17] |